Sign in

CIK 0001427925

  • Non-accelerated filer
  • Smaller reporting company

TALPHERA, INC.

Sign in to watch
Ticker
TLPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
412193603
Phone
+1 650-216-3500
Business address
1850 GATEWAY DRIVE, SUITE 175, SAN MATEO, CA, 94404
Former names
ACELRX PHARMACEUTICALS INC
  1. 4 Grant or award Chief Executive Officer acquired 200,000 shares (grant or award)
  2. 5 Insider Annual Insider Trading Report
  3. 4 Open-market buy Chief Executive Officer bought 3,610 shares at $2.78 ($10,024)
  4. 4 Open-market buy Chief Financial Officer bought 5,000 shares at $2.78 ($13,883)
  5. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $2.99 ($29,890)
  6. 4 Open-market buy Chief Medical Officer bought 16,000 shares at $3.07 ($49,120)
  7. 4 Open-market buy Director bought 20,700 shares at $2.82 ($58,376)
  8. 4 Open-market buy Chief Financial Officer bought 5,000 shares at $3.13 ($15,646)
  9. 4 Returned to the company Chief Development Officer returned 5,000 shares (to the company)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market sale Chief Development Officer sold 5,216 shares at $5.00 ($26,080)
  15. 4 Open-market sale Chief Engineering Officer sold 28,351 shares at $5.00 ($141,755)
  16. 4 Open-market sale Chief Development Officer sold 6,953 shares at $4.50 ($31,289)
  17. 4 Grant or award Chief Engineering Officer acquired 8,022 shares (grant or award)
  18. 4 Grant or award Chief Financial Officer acquired 10,000 shares (grant or award)
  19. 4 Grant or award Chief Executive Officer acquired 6,040 shares (grant or award)
  20. 4 Grant or award Chief Development Officer acquired 6,876 shares (grant or award)

Page 10 of 21 · 404 filings